News

New Brighton Collaboration Case Definition Companion Guide for TTS-VITT

The Companion Guide to the Brighton Collaboration Case Definition for Thrombosis with Thrombocytopenia Syndrome (TTS) and Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT) is now available

This guide includes ICD-9/10-CM, MedDRA & SNOMED CT codes, background rates, risk factors, & guidance for real-time investigation, data collection, & analysis. Also tools e.g. a data abstraction & interpretation form, and a tabular summary of key case definition criteria Read more

Eyes on Disease X: Ranking the Next Pandemic

Article by Jane Fieldhouse, David Wolking, Nistara Randhawa, Timothy Endy, & Angel Desai, published in Think Global Health

This article identifies threats associated with Disease X, e.g. the potential for an unknown pathogen to emerge & challenges in developing countermeasures against novel viruses. It also highlights the risk of zoonotic spillover events & the need for enhanced surveillance ... Read more

New SPEAC video about Brighton Case Definitions

Brighton Collaboration has developed more than 80 Brighton Case Definitions for adverse events following immunization (AEFI) and adverse events of special interest (AESI). The case definitions are designed to support vaccine safety studies across the entire lifespan of a vaccine. Read more

ECOWAS-RegECs Project

Practical strengthening of regulatory and ethics oversight on clinical trials in West Africa using Lassa Fever vaccine development projects and increase regulatory maturity level in targeted countries

The project is about improving capabilities of Regulators & Ethics Experts in vaccines clinical research oversight and enhancing the Maturity Level of selected ECOWAS NRAs by focused support through FDA Ghana on regulatory systems and clinical trial functions Read more

Vaccination Programmes: Epidemiology, Monitoring, Evaluation

Textbook by Susan Hahné, Kaatje Bollaerts, Paddy Farrington

With the support of CEPI, the Open Access version of this textbook is now available to all. It discusses how epidemiologic methods can be used to study, in real life, vaccination programmes’ impacts, benefits and risks Read more

OLDER NEWS HERE |

Articles